News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Oryzon-Asebio-Biotecnologia
ORYZON reports financial results and corporate updates for half-year ending June 30, 2023
Corporate
Partners - Oryzon Genomics
Orikine
Orikine Bio closes €5.5m Series Seed Financing with Sabadell Asabys and AdBio
Financing · Corporate
New synthetic biology spin-off from the Centre for Genomic Regulation (CRG) in Barcelona developing…
Partners - Asabys Partners
Biorreactores empleados en VIVEbiotech
VIVEbiotech participates in the European MAGIC project
Healthcare · Personalized medicine · Advanced therapies · Gene editing · International · EU projects · Financing
VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to…
Partners - VIVEbiotech
Primera conferencia Cátedra UAM PEACHES
The use of cell secretomes opens a new era of advanced therapies
Drug discovery · Innovative drugs · Personalized medicine · Advanced therapies
The UAM-PEACHES Chair on cell therapies has taken place at the Autonomous University of Madrid (UAM…
Partners - PEACHES BIOTECH S.L.
Paciente_ensayo
Positive aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borderline Personality Disorder
Access to innovation
Recommendation from the independent Data Monitoring Committee (DMC) to continue the PORTICO trial…
Partners - Oryzon Genomics
Oryzon-Asebio-Biotecnologia
ORYZON Announces Voting Results from its 2023 Annual General Meeting of Shareholders
Corporate
All resolutions were approved and 35% of the issued shares represented.
Partners - Oryzon Genomics
Fundación_Medina_Welab_AseBio
WeLab Barcelona and Fundación MEDINA will collaborate to expand the offer of R&D services and capabilities for the discovery and development of new medicines
Innovative drugs
This collaboration allows combining experience and resources for the discovery and development of…
Partners - Fundación Medina
Oficina_Genesis_Biomed_Valencia
GENESIS Biomed opens a new office in Valencia
Corporate
This new location of GENESIS Biomed in the BioHub joins the existing locations in Barcelona and…
Partners - GENESIS Biomed
Thomas_Harth_Ysios
Tagworks Pharmaceuticals Announces $64 Million in Series A Financing to Advance Click-to-Release Therapeutics
Access to innovation
Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture…
Partners - Ysios Capital Partners